Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.54

+3.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (3478)	6/10/1997 7:02:00 AM
From: Henry Niman	of 32384

All of the new protocols are listed as active except the UCLA study on combination therapy for advanced renal cancer (its listed as approved, but not yet active). However, a similar protocol submitted by Yale investigators was already active in the submission dated 8/96. Moreover, a similar protocol at Colorado: Renal LIGAND IRB# 7656 A Multicenter Phase II Evaluation of a Combination Therapy of Targretin Oral Capsules (LGD1069) and Intron A (Interferon-alfa-2b) in Patients with Advanced Renal Cell Carcinoma. PI: Petrylak, MD Contact Person: Tim Judge has been up for many months now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next